Skip to content
The Nexus
HEALTHApr 8 · 00:00 UTCNATURE NEWSAdam Auton

Genetic predictors of GLP1 receptor agonist weight loss and side effects

A study published in Nature identifies genetic variants linked to the effectiveness and side effects of GLP1 receptor agonist medications. These findings could advance precision medicine strategies for obesity treatment by enabling personalized therapeutic approaches.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned
Spot something wrong with this article?Report a problem →
Forward this